Field
Biotechnology products and medical services
Address
43 Ave. No.1414 / 14 and 18. Miramar. Playa
Contact person's name
Lic. Silvia Rafaela Vera Shelton, General Director
Short description of the company
The Company was founded on April 25, 1986. Is a reference institution in the world. Has more than 35 years of expertise in research, development, production and marketing of medicines, cosmetics and nutrient derived from the human placenta. Offers specialized medical services in Vitiligo, Psoriasis and Alopecia. The company's mission is to research, produce and commercialize products derived from the human placenta, natural and biotechnological products, as well as to provide medical services to satisfy the needs and expectations of our customers.
Company`s description
The company aims to be a leader in research, production, marketing and dermatological medical services with innocuous products derived from human placenta and others, supported by a certified integrated management system, with competitive personnel, stimulating exports of products and services, promoting strategic alliances. It has a Clinic that provides medical services structured in programs for the diagnosis and treatment of patients with Vitiligo, Psoriasis and Alopecia. Quality of life services will be offered in the future.
Products and services description in www.histoterapia-placentaria.cu
Partner search
partner search
Field
Biotechnology products and medical services
Short content description
BUSINESS MODELS OFFERED BY HISPLACEN TO POTENTIAL PARTNERS
1. Agency contract for the shipment to Cuba of patients with Vitiligo, Psoriasis and Alopecia.
2. Commercialization of medicines, nutrients and dermocosmetics.
3. Commercialization of human placental extracts - EPH for the formulation, filling and packaging of the finished product in the commercialization territories.
4. Productive linkages with cuban entities in order to have more comprehensive offers of products and services and strengthen the commercialization markets.
5. Co-development of products for the improvement of existing formulations and development of new ones.
6. Foreign investment in Cuba in the modality of Joint Venture or other applicable to the Project
The programme is co-financed by the Slovenian Enterprise Fund and the European Union, namely from the European Fund for Regional Development. It is carried out on the basis of the Substantial Support of Fund Recipients (SME) programme from 2018 to 2023 within the framework of the Operational Programme for the Implementation of European Cohesion Policy from 2014 to 2020.
